Interview with Dr. Nathan Pennell: How Broad NGS Testing Can Save Lives and Potentially Reduce Costs

Caris Molecular Minute Podcast Series

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Nathan Pennell, Co-Director of the Cleveland Clinic Lung Cancer Program and Vice Chair of Clinical Research for the Taussig Cancer Institute. Together they discuss the methodology and results of a recent JCO paper for which Dr. Pennell was a senior author: Modeling Costs and Life-Years Gained by Population-Wide NGS or Single-Gene Testing in Nonsquamous Non–Small-Cell Lung Cancer in the US. For more information, please visit: www.CarisLifeSciences.com